Article
Allosteric MAPKAPK2 Inhibitors Improve Plaque Stability in Advanced Atherosclerosis
2021-01-12
Abstract excerpt
<h4>ABSTRACT</h4> Atherosclerotic vascular disease resulting from unstable plaques is the leading cause of morbidity and mortality in subjects with type 2 diabetes (T2D), and thus a major therapeutic goal is to discover T2D drugs that can also promote atherosclerotic plaque stability. Genetic or pharmacologic inhibition of mitogen-activated protein kinase-activated protein kinase-2 (MK2) in obese mice improves gl...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c6cf19d9-4a31-5336-abe2-d95d19e26cee
- DOI
- 10.1101/2021.01.12.426264
